Be the Cure aims to educate Albertans about how they can be a part of health research. We provide information about the different types of research and offer ways to take part through the Albertans4HealthResearch Network and clinical research database. Through our efforts, we hope to increase the number of people who are making a difference in health research in our province.
Be The Cure has been made possible through the following organizations coming together to support our cause: Alberta Health Services, Northern Alberta Clinical Trials and Research Centre (NACTRC), University of Alberta, University of Calgary, and Alberta Innovates.
You can also search for actively recruiting research studies at the University of Calgary.
THIS IS JUST SOME OF THE RESEARCH HAPPENING IN ALBERTA.
WHAT IS HEALTH RESEARCH DOING?
Research is changing the way our health care system provides services every day. Here are a few examples of discoveries made right here in Alberta.
Dr. John Remmers (University of Calgary) discovers that narrowing of the pharyx causes sleep apnea. He creates the CPAP machine, the current world standard of treatment.
The Islet Transplant Group (University of Alberta) carries out Canada’s first islet transplant. This is one step in the quest to find better diabetes treatments.
Dr. Sam Weiss (University of Calgary) discovers neural stem cells in adult mammal brains. This leads to new approaches for brain cell replacement and repair. It also dispels false ideas that the brain can’t regenerate.
Dr. Shapiro (University of Alberta) works with the Islet Transplantation Group to develop The Edmonton Protocol. This reduces dependence on insulin in people with Type 1 diabetes.
Researchers create a technique so people with severe Type 1 diabetes can stop taking insulin for a short time. This makes treatment safer and more convenient for patients.
A trans-cranial Doppler device shows doctors if an intravenous stroke treatment works. Ultrasound waves determine if arteries are open and how blood is flowing.
The Zeidler Gastrointestinal Health Centre opens. This is Canada’s first clinical facility dedicated to gastroenterology.
Researchers find a new way to treat E. coli by keeping the bacterium from reaching the kidneys.
A researcher finds a biomarker in prostate cancer patients that tells doctors if the cancer will come back or spread. This way they can treat patients earlier and more aggressively.
University of Calgary researchers make a key advance in connecting brain cells to a silicon chip. This “neurochip” screens drugs for patients with brain disorders and determines which ones are likely to be effective.
Dr. Garnette Sutherland and a team at the University of Calgary develop the world’s first MRI-compatible surgical robot. It’s capable of both microsurgery and image-guided biopsy.
Dr. Derrick Rancourt and Dr. Roman Krawetz (University of Calgary) create bioreactor technology that allows millions of stem cells to produce without the risk of cancer.
Inspired by a complex suture pattern, an Edmonton doctor develops a wound-clamping device to stop hemorrhaging, one of the leading causes of preventable death.
Alberta researchers learn that a vaccine developed from a single hepatitis viral strain is effective against all known strains of the virus.
Researchers at the Cross Cancer Institute combine two existing drugs to double the life expectancy of patients with multiple myeloma.
A non-invasive, electrode-based cardiac system gives real-time access to heart data without the use of a catheter. This reduces patient discomfort and lowers the time spent gathering cardiac readings from hours to minutes.
A surgical robot joins the staff at the Lois Hole Hospital for Women to help patients with uterine and cervical cancer. Surgeries now result in less pain, less bleeding, and faster recovery.
The Alberta-run ESCAPE Trial leads to a groundbreaking stroke treatment procedure. As a result, the number of stroke-related deaths lowers by 50%.
Researchers at the University of Alberta identify ways to repair gene malfunction and prevent heart failure in patients with Duchenne muscular dystrophy.
Dr. David Eisenstat and his research team (University of Alberta) find that mutations in two genes can affect brain development. This could lead to new therapies for some people with autism and seizure disorders.
University of Alberta scientists find that a drug used to treat hepatitis could slow disease progression in ALS patients.
A cardiac research team (University of Alberta) finds that a synthetic peptide can help save more patients with aortic aneurysms.
Research is helping advance knowledge, improve our world, and shape the future.